Diroximel Fumarate in Relapsing Forms of Multiple Sclerosis: A Profile of Its Use.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Works matching IS 11727047 AND DT 2021 AND VI 35 AND IP 6
Results: 9
1
2
Correction to: OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
3
Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status.
- Published in:
- 2021
- By:
- Publication type:
- journal article
4
Irritability in Mood Disorders: Neurobiological Underpinnings and Implications for Pharmacological Intervention.
- Published in:
- 2021
- By:
- Publication type:
- journal article
5
The NOP Receptor System in Neurological and Psychiatric Disorders: Discrepancies, Peculiarities and Clinical Progress in Developing Targeted Therapies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
6
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug-Drug Interactions and Tolerability.
- Published in:
- 2021
- By:
- Publication type:
- journal article
7
Erythropoietin Improves Poor Outcomes in Preterm Infants with Intraventricular Hemorrhage.
- Published in:
- CNS Drugs, 2021, v. 35, n. 6, p. 681, doi. 10.1007/s40263-021-00817-w
- By:
- Publication type:
- Article
8
Effect of a Multi-Layer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adults with ADHD: A Randomized, Double-Blind, Forced-Dose, Placebo-Controlled Trial Followed by a 6-month Open-Label Extension.
- Published in:
- 2021
- By:
- Publication type:
- journal article
9
Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study.
- Published in:
- CNS Drugs, 2021, v. 35, n. 6, p. 655, doi. 10.1007/s40263-021-00809-w
- By:
- Publication type:
- Article